CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$33.50
+2.59 (+8.38%)
Open$31.21
Previous Close$30.91
Day High$33.64
Day Low$31.06
52W High$40.37
52W Low$4.30
Volume—
Avg Volume920.3K
Market Cap1.79B
P/E Ratio—
EPS$-2.26
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+86.4% upside
Current
$33.50
$33.50
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.52M | 187.20M | 168.99M |
| Net Income | -55,455,340 | 36.18M | 32.84M |
| Profit Margin | -181.7% | 19.3% | 19.4% |
| EBITDA | -56,521,974 | 59.64M | 51.36M |
| Free Cash Flow | — | 19.67M | 27.43M |
| Rev Growth | +352.7% | +21.4% | +1.7% |
| Debt/Equity | 0.02 | 1.29 | 1.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |